← Back to Nuqta Atlas
Editorially curated · qa-hmc-qbb-tissue-biobank
HMC-Qatar Biobank Tissue Biobank Service
Research service opening HMC's archival pathology collection and new fresh-tissue infrastructure to approved molecular and genomic studies.
01 / Project overview
What the record establishes.
- Geographic scope
- National HMC pathology archive and prospective collections
- Project type
- clinical tissue biobank
- Research domain
- pathology, cancer research, molecular medicine, and genomics
- Years
- 2023–
- Lifecycle status
- operational
- Status basis
- HMC launched phase one on 15 January 2023 and provides an application pathway for researchers; phase two adds prospective fresh tissue.
- Status evidence date
- 2026-08-15
- Scale
- More than 300,000 diverse surgical pathology specimens accumulated since 2008; phase one covers FFPE material, with fresh tissue planned/implemented in phase two.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Hamad Medical Corporation Department of Laboratory Medicine and Pathology · Qatar Biobank
- Partner organizations
- Qatar Precision Health Institute
- Organism / population
- Patients undergoing surgery or biopsy in the HMC system
03 / Data and access
What exists and how it can be reached.
Data types
- FFPE tissue
- fresh tissue
- histopathology
- linked clinical data
- molecular/genomic assays
Data access
Researchers apply through Qatar Biobank, HMC pathology, ABHATH, and required IRB/MRC approvals.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National-scale reusable clinical tissue collection with a formal research-access pathway and molecular/genomic utility.
Editorial note
The 300,000 figure is specimens, not unique patients.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0